Skip to main content

Second Malignancies after Radiation for Breast Cancer

  • Chapter
  • First Online:
Toxicities of Radiation Treatment for Breast Cancer
  • 771 Accesses

Abstract

This chapter explores the risk of second malignancies after breast radiotherapy. Meta-analyses of registry studies and randomized controlled trials have shown an elevated risk of in-field malignances after adjuvant radiotherapy for breast cancer. The relative risk increases with increasing latency post radiotherapy. The scientific literature evaluating the risk of lung cancer, esophageal cancer, sarcoma, and contralateral breast cancer in the context of patient-specific risk factors is explored in detail. The risk of second malignancy based on radiotherapy technique is also reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Cahan WG, Woodward HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone. Cancer. 1958;1:3–28.

    Article  Google Scholar 

  2. Grantzau T, Mellemkjær L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol. 2013;106(1):42–9. https://doi.org/10.1016/j.radonc.2013.01.002.

    Article  PubMed  Google Scholar 

  3. Arlen M, Higinbotham NL, Huvos AG, et al. Radiation-induced sarcoma of bone. Cancer. 1971;28:1087–99.

    Article  CAS  Google Scholar 

  4. Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114(1):56–65. https://doi.org/10.1016/j.radonc.2014.10.004.

    Article  PubMed  Google Scholar 

  5. Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9. https://doi.org/10.1200/JCO.2016.72.0722.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Grantzau T, Skovhus M, Væth M, Overgaard J. Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol. 2014;111(3):366–73. https://doi.org/10.1016/j.radonc.2014.05.004.

    Article  PubMed  Google Scholar 

  7. Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer. 2003;98(7):1362–8. https://doi.org/10.1002/cncr.11655.

    Article  PubMed  Google Scholar 

  8. Zablotska LB, Neugut AI. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer. 2003;97(6):1404–11. https://doi.org/10.1002/cncr.11214.

    Article  PubMed  Google Scholar 

  9. Milano MT, Strawderman RL, Venigalla S, et al. Non – small-cell lung cancer after breast cancer. J Thorac Oncol. 2014;9(8):1081–90. https://doi.org/10.1097/JTO.0000000000000213.

    Article  PubMed  Google Scholar 

  10. Henson KE, Mcgale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2012;108(1):179–82. https://doi.org/10.1038/bjc.2012.575.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ford MB, Sigurdson AJ, Petrulis ES, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003;98(7):1457–64. https://doi.org/10.1002/cncr.11669.

    Article  PubMed  Google Scholar 

  12. Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26(3):392–8. https://doi.org/10.1200/JCO.2007.13.3033.

    Article  PubMed  Google Scholar 

  13. Depla L, Scharloo-Karels CH, de Jong M, et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014;50(10):1779–88. https://doi.org/10.1016/j.ejca.2014.03.002.

    Article  CAS  PubMed  Google Scholar 

  14. Torres KE, Ravi V, Kin K, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013;20(4):1267–74. https://doi.org/10.1245/s10434-012-2755-y.

    Article  PubMed  Google Scholar 

  15. Taghian A, de Vathaire F, Terrier P, et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:361–7.

    Article  CAS  Google Scholar 

  16. Yap J, Chuba PJ, Thomas R, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231–7.

    Article  Google Scholar 

  17. Stovall M, Smith SA, Langholz BM, et al. Dose to the contralateral breast from radiation therapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008;72(4):1021–30. https://doi.org/10.1016/j.ijrobp.2008.02.040.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Boice JD, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992;326(12):781–5.

    Article  Google Scholar 

  19. Storm HH, Andersson M, Boice JDJ, et al. Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst. 1992;84(16):1245–50.

    Article  CAS  Google Scholar 

  20. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56(4):1038–45. https://doi.org/10.1016/S0360-3016(03)00203-7.

    Article  PubMed  Google Scholar 

  21. Drooger JC, Akdeniz D, Pignol J-P, et al. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age. Breast Cancer Res Treat. 2015;154(1):171–80. https://doi.org/10.1007/s10549-015-3597-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hooning MJ, Aleman BMP, Hauptmann M, et al. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol. 2008;26(34):5561–8. https://doi.org/10.1200/JCO.2007.16.0192.

    Article  PubMed  Google Scholar 

  23. Salminen EK, Pukkala E, Kiel KD, Hakulinen TT. Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer. Int J Radiat Oncol Biol Phys. 2006;65(3):699–704. https://doi.org/10.1016/j.ijrobp.2006.01.017.

    Article  PubMed  Google Scholar 

  24. Zablotska LB, Chak A, Das A, Neugut AI. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am J Epidemiol. 2005;161(4):330–7. https://doi.org/10.1093/aje/kwi050.

    Article  PubMed  Google Scholar 

  25. Morton LM, Gilbert ES, Hall P, et al. Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol. 2012;23(12):3081–91. https://doi.org/10.1093/annonc/mds144.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hamilton SN, Tyldesley S, Li D, Olson R, Mcbride M. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation? Radiat Oncol Biol. 2015;91(5):977–85. https://doi.org/10.1016/j.ijrobp.2014.12.051.

    Article  Google Scholar 

  27. Abo-madyan Y, Hammad M, Aly MMOM, et al. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol. 2014;110(3):471–6. https://doi.org/10.1016/j.radonc.2013.12.002.

    Article  PubMed  Google Scholar 

  28. Santos AMC, Marcu LG, Wong CM, et al. Risk estimation of second primary cancers after breast radiotherapy. Acta Oncol. 2016;55(11):1331–7. https://doi.org/10.1080/0284186X.2016.1185150.

    Article  PubMed  Google Scholar 

  29. Zurl B, Stranzl H, Winkler P, Kapp KS. Quantification of contralateral breast dose and risk estimate of radiation-induced contralateral breast cancer among young women using tangential fields and different modes of breathing. Int J Radiat Oncol Biol Phys. 2013;85(2):500–5. https://doi.org/10.1016/j.ijrobp.2012.04.016.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah Nicole Hamilton .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hamilton, S.N. (2019). Second Malignancies after Radiation for Breast Cancer. In: Wright, J. (eds) Toxicities of Radiation Treatment for Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-11620-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11620-0_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11619-4

  • Online ISBN: 978-3-030-11620-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics